Uždaroji akcinė bendrovė "Profarma" Finance - revenue, profit
EBITDA margin (%)
Register and
explore Okredo dataEBIT margin (%)
Register and
explore Okredo data| Indicator |
|---|
| Turnover (€) |
| Sales per employee (€) |
| Profit before tax (€) |
| Net Profit (€) |
| Profit per employee (€) |
| Total profitability (%) |
| Net profitability (%) |
| Equity (€) |
| Amounts Payable And Liabilities (€) |
| Non-current Assets (€) |
| CurrentAssets (€) |
| Working capital requirement |
| Debt-to-equity ratio |
| EBITDA margin (%) |
| EBITDA (€) |
| EBIT margin (%) |
| EBIT (€) |
| 2022 |
|---|
| 635,377 |
| 33,959 |
| 4,764 |
| 4,764 |
| 255 |
| 65.02 |
| 0.75 |
| 405,790 |
| 1,240,520 |
| 619,518 |
| 1,315,785 |
| 0.94 |
| 3.06 |
| - |
| - |
| 5.04 |
| 32,038 |
| 2023 |
|---|
| 1,905,815 |
| 95,866 |
| 453,074 |
| 453,074 |
| 22,790 |
| 52.20 |
| 23.77 |
| 858,864 |
| 1,025,870 |
| 970,094 |
| 1,341,078 |
| 0.42 |
| 1.19 |
| - |
| - |
| 25.03 |
| 477,048 |
| 2024 |
|---|
| 1,262,522 |
| 50,562 |
| 16,378 |
| 16,378 |
| 656 |
| 44.07 |
| 1.30 |
| 864,834 |
| 1,209,497 |
| 787,919 |
| 1,288,164 |
| 0.45 |
| 1.40 |
| - |
| - |
| 3.15 |
| 39,769 |
| 2024 |
|---|
| 1,262,522 |
| 50,562 |
| 16,378 |
| 16,378 |
| 656 |
| 44.07 |
| 1.30 |
| 864,834 |
| 1,209,497 |
| 787,919 |
| 1,288,164 |
| 0.45 |
| 1.40 |
| - |
| - |
| 3.15 |
| 39,769 |
Turnover (€)
2024
Turnover (€)
1,262,522 €-34 % *
Sales per employee (€)
50,562 €-47 % *
Profit before tax (€)
16,378 €-96 % *
Net Profit (€)
16,378 €-96 % *
Profit per employee (€)
656 €-97 % *
Total profitability (%)
44.07 %-15.57 % *
Net profitability (%)
1.30 %-94.53 % *
Equity (€)
864,834 €1 % *
Amounts Payable And Liabilities (€)
1,209,497 €18 % *
Non-current Assets (€)
787,919 €-19 % *
CurrentAssets (€)
1,288,164 €-4 % *
Working capital requirement
0.45 7.14 % *
Debt-to-equity ratio
1.40 17.65 % *
EBITDA margin (%)
-EBITDA (€)
-EBIT margin (%)
3.15 %-87.42 % *
EBIT (€)
39,769 €-92 % *
